Industry News
Pharmaceutical Industry News
‘The Top Line’ podcast: The aftermath of Roche’s failed TIGIT, Big Pharma’s Q1 growth vs. mRNA stars, plus this week’s headlines
'The Top Line' podcast: The aftermath of Roche's failed TIGIT, Big Pharma's Q1 growth vs. mRNA stars, plus this week's headlines tcarey Thu, 05/19/2022 - 13:43
Catalent throws down $175M on yet another manufacturing expansion
Catalent throws down $175M on yet another manufacturing expansion fkansteiner Thu, 05/19/2022 - 13:10
Unlocking Patient Access and Product Success in a Digital Healthcare World
Unlocking Patient Access and Product Success in a Digital Healthcare World jfrasor Thu, 05/19/2022 - 11:58
After Big Pharma pulls back in Russia, Dr. Reddy’s says business is booming
After Big Pharma pulls back in Russia, Dr. Reddy's says business is booming kdunleavy Thu, 05/19/2022 - 10:54
Eli Lilly revs up immunology engine as Olumiant cruises toward coveted alopecia green light
Eli Lilly revs up immunology engine as Olumiant cruises toward coveted alopecia green light fkansteiner Thu, 05/19/2022 - 10:22
As monkeypox cases emerge in US and Europe, Bavarian Nordic inks vaccine order
As monkeypox cases emerge in US and Europe, Bavarian Nordic inks vaccine order aliu Thu, 05/19/2022 - 09:52
The Path to a More Data-Driven Understanding of the Specialty Drug Patient Journey
The Path to a More Data-Driven Understanding of the Specialty Drug Patient Journey mwen Thu, 05/19/2022 - 09:21
Syringe maker ApiJect reels in $111M in private investment round
Syringe maker ApiJect reels in $111M in private investment round jkeenan Thu, 05/19/2022 - 08:23
Amid a push to bulk up in Latin America, Procaps buys Mexican drugmaker Grupo Somar
Amid a push to bulk up in Latin America, Procaps buys Mexican drugmaker Grupo Somar zbecker Thu, 05/19/2022 - 08:19
Johnson & Johnson gets pulmonary hypertension nurses talking with live online educational campaign
Johnson & Johnson gets pulmonary hypertension nurses talking with live online educational campaign sharon.coey Thu, 05/19/2022 - 07:34
Troubles for Bayer and AbbVie? Their market cap in Q1 tells a different story: report
Troubles for Bayer and AbbVie? Their market cap in Q1 tells a different story: report kdunleavy Thu, 05/19/2022 - 07:03
After high-profile US rejection for roxadustat, Astellas touts its safety in new pooled analysis
After high-profile US rejection for roxadustat, Astellas touts its safety in new pooled analysis fkansteiner Wed, 05/18/2022 - 20:22
NIH in talks with Pfizer to study a longer course of COVID drug Paxlovid, Fauci says
NIH in talks with Pfizer to study a longer course of COVID drug Paxlovid, Fauci says zbecker Wed, 05/18/2022 - 16:12
‘Pharma bro’ Shkreli no longer behind bars—but his lifetime industry ban remains in place
'Pharma bro' Shkreli no longer behind bars—but his lifetime industry ban remains in place fkansteiner Wed, 05/18/2022 - 16:01
Moderna chairman Afeyan defends hiring practices after CFO debacle: report
Moderna chairman Afeyan defends hiring practices after CFO debacle: report kdunleavy Wed, 05/18/2022 - 11:18
Pfizer holding on tight to supplies of COVID-19 drug Paxlovid, limiting the prospect of combination research: report
Pfizer holding on tight to supplies of COVID-19 drug Paxlovid, limiting the prospect of combination research: report zbecker Wed, 05/18/2022 - 10:36
Roche, bluebird bio settle gene therapy trademark suit around ‘spark’ sickle cell disease campaign
Roche, bluebird bio settle gene therapy trademark suit around ‘spark’ sickle cell disease campaign aliu Wed, 05/18/2022 - 10:33
J&J partner Aspen, with no orders for its COVID shot, warns low demand sends ‘bad message’
J&J partner Aspen, with no orders for its COVID shot, warns low demand sends 'bad message' fkansteiner Wed, 05/18/2022 - 09:13
Novartis sells UK plant after delay, costing 212 workers their jobs
Novartis sells UK plant after delay, costing 212 workers their jobs zbecker Wed, 05/18/2022 - 08:07
‘Startup like no other’: China’s Hengrui launches Luzsana with Big Pharma veterans at the top and a goal to improve drug access
'Startup like no other': China's Hengrui launches Luzsana with Big Pharma veterans at the top and a goal to improve drug access aliu Wed, 05/18/2022 - 05:32